MedPath

Cognitive impairment in bipolar disorder treated with aripiprazole (memory, alertness, etc.)

Conditions
Bipolar disorder is among the most severely debilitating diseases. Patients with bipolar disorder generally experience high rates of relapse, a chronic recurrent course, lingering residual symptoms, functional impairment, psychosocial disability and diminished well-being. More recent data have underlined the importance of neurocognitive impairments in the euthymic state including impairments in attention, memory and executive function.
Registration Number
EUCTR2009-017581-22-DE
Lead Sponsor
Department of Psychiatry and Psychotherapy, Charity University Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Bipolar Disorder (BP I + BP II)
Ethymic mood state since 6 months at least
Stable medication with mood stabilizers
Age > 18 y.
Cognitive Impairment measured on self reporting questionnaires
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Axis 1 condition other than bipolar disorder during last 6 month
organic brain disorder
pregnancy or breast feeding

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To improve baseline cognitive functioning regarding verbal memory by 12 weeks aripiprazole add-on therapy in bipolar, euthymic patients.<br><br>;Secondary Objective: Secondary endpoints are the changes in cognitive functioning in the following domains: <br><br>1.working memory <br><br>2.executive functioning <br><br>3.attention<br>;Primary end point(s): Primary endpoint is change in verbal memory function measured with California Verbal Learning Test (CVLT).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath